| Market Cap | ₹1,310.16 CrSmall Cap |
|---|---|
| TTM P/E | 33.33Sector PE 51.14 |
| Revenue Growth | 11.74%Year-on-Year Qtr |
| RSI | 31.7Near Oversold |
Key highlights
- CMHO Jabalpur issued the resumption order on October 28, 2026
- Approval follows successful completion of renovation and safety measure implementation
- Full healthcare services including patient admissions have resumed on the affected floor
- Company reported Q1 FY27 revenue of ₹331.22 crore, up 11.7% year-on-year
- Promoter holding remains stable at 74.33% as of the latest quarter
Restoring Full Service Capacity in Jabalpur
Shalby Limited has announced that its hospital facility in Jabalpur is now fully operational. The Chief Medical and Health Officer (CMHO) of Jabalpur issued a formal permission letter on October 28, 2026, allowing the hospital to resume normal activities on its previously affected floor. This development follows a period of renovation and a subsequent reassessment by competent authorities to ensure all safety protocols were met.
The restoration of this floor allows for a complete range of healthcare services, including the admission of new patients, effectively bringing the entire facility back to full capacity after recent operational disruptions mentioned in earlier October disclosures.
Operational Milestones and Safety Compliance
- CMHO Jabalpur expressed satisfaction with the fulfillment of stipulated safety conditions
- The resumption follows company letters dated October 14 and 17 regarding floor status
- Permission covers all regular healthcare services and patient admission protocols
- Renovation work was assessed and approved by local regulatory authorities
- The hospital has now integrated the previously restricted floor into daily operations
Financial Performance and Strategic Context
In the quarter ended June 30, 2026, Shalby Limited reported an operating revenue of ₹331.22 crore, marking an 11.74% growth over the previous year. While net profit for the quarter stood at ₹10.84 crore, the company maintains a healthy TTM P/E of 33.33x, which sits below the industry average of 53.84x. This regulatory clearance in Jabalpur aligns with Shalby's broader track record of securing critical approvals, such as the kidney transplant certification in Ahmedabad received in April 2026 and US FDA 510(k) clearance for its proprietary knee replacement device in early 2025.
Resumption of Operations
The authority has expressed its satisfaction with the compliance and fulfilment of the stipulated terms and conditions. Accordingly, the hospital is now permitted to resume its regular healthcare services, including admission of patients on the previously affected floor.
| Date | Announcement | Amount |
|---|---|---|
| 11 Apr 2026 | Received regulatory approval for Kidney Transplant services at Krishna Shalby Hospital, Ahmedabad for a period of 5 yearsSource: BSE filing | – |
| 11 Feb 2025 | Received regulatory approval for registration to perform Hand Transplants at Shalby Hospital, Ahmedabad from the Government of GujaratSource: accessdata.fda.gov | – |
| 15 Jan 2025 | Received US FDA 510(k) premarket clearance for Duraniom™ Primary Total Knee Replacement device with TiNbN coating by subsidiary Shalby Advanced Technologies Inc.Source: shalby.org | – |
What to watch next
- Q2 FY27 financial results announcement scheduled for November 3, 2026
- Normalization of standalone hospital EBITDA margins to ~20% targeted for Q2 FY27
- Launch of 3–4 new global products by Shalby MedTech division during FY27
- Progress on the ₹250 crore Santacruz Mumbai hospital facility due for FY 2030-31
| Share price | ₹121.3 |
|---|---|
| Market capitalisation | ₹1,310.16 Cr |
| Revenue (annual) | ₹1,141.43 Cr |
| Net profit (annual) | ₹37.39 Cr |
| Revenue (latest quarter) | ₹331.22 Cr+15.23% vs previous quarter |
| Net profit (latest quarter) | ₹10.84 Cr-40.80% vs previous quarter |
| P/E (TTM) | 33.33×Sector 51.14× |
| Promoter holding | 74.33%0.00% QoQ |
| FII holding | 4.65%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Shalby Limited announcing the resumption of full operations at Shalby Hospital, Jabalpur. Market figures from a third-party data provider.
